Therapeutic Solutions International (TSOI) announced preliminary results of a collaboration with the Veltmeyer Institute for Advanced Therapeutics aimed at providing patients with protocols, products and cells, developed by the Company. As part of the collaboration, the Veltmeyer Institute provided an update on the first three patients treated.
Therapeutic Solutions International, Inc.
Equities
TSOI
US8833781011
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000701 USD | -12.38% | +40.00% | -30.00% |
1st Jan change | Capi. | |
---|---|---|
-30.00% | 3.08M | |
-5.10% | 11.34B | |
+4.02% | 9.11B | |
+38.12% | 5.53B | |
-23.70% | 4.61B | |
+8.55% | 3.45B | |
-6.44% | 2.87B | |
-5.85% | 2.1B | |
-11.84% | 2.08B | |
-23.36% | 1.78B |
- Stock Market
- Equities
- TSOI Stock
- News Therapeutic Solutions International, Inc.
- Therapeutic Solutions International Announces Improvements in Autism, Amyotrophic Lateral Sclerosis and Schizophrenia Cases Treated by Veltmeyer Institute for Advanced Therapeutics